@article{Ratcliff_J-2021_80800,
title = {Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection},
author = {Ratcliff, J. and Nguyen, D. and Fish, M. and Rynne, J. and Jennings, A. and Williams, S. and Al-Beidh, F. and Bonsall, D. and Evans, A. and Golubchik, T. and Gordon, A. and Lamikanra, A. and Tsang, P. and Ciccone, N. and Leuschner, U. and Laing, E. and Slack, W. and Mouncey, P. and Ziyenge, S. and Oliveira, M. and Ploeg, R. and Rowan, K. and Shankar-Hari, M. and Roberts, D. and Menon, D. and Estcourt, L. and Simmonds, P. and Harvala, H. and REMAP-CAP Immunoglobulin Domain UK Investigators},
month = {may},
year = {2021},
abstract = {BACKGROUND: Convalescent plasma containing neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is under investigation for coronavirus disease 2019 (COVID-19) treatment. We report diverse virological characteristics of UK intensive care patients enrolled in the Immunoglobulin Domain of the REMAP-CAP randomized controlled trial that potentially influence treatment outcomes.},
pages = {595-605},
volume = {224},
issue = {4},
journal = {The Journal of Infectious Diseases},
publisher = {Oxford University Press},
url = {https://doi.org/10.1093/infdis/jiab283},
}
